Titan Biotech Shares Surge After Stock Split
Shares of organic product manufacturer Titan Biotech experienced a 20 % surge, reaching 312 on February 20, complying with a 1: 5 supply split. The split, announced in November, intended to boost liquidity and attract retail capitalists.
- Stock Split: The 1: 5 split raised outstanding shares fivefold, adjusting the rate to 260 per share.
- Financial Efficiency: Q 3 FY 26 saw an internet earnings of 8 53 crore, up from 4 39 crore year-over-year, with income climbing 47 6 % to 56 51 crore.
- Shareholding: Promoters hold 55 8 % of the stake, while retail capitalists hold 44 2 %.
